Lexology February 27, 2024
Bradley Arant Boult Cummings LLP

As we do every year, this issue revisits the key cases and other developments from the year gone by. And by most metrics, 2023 was a notable year for the False Claims Act (FCA).

We start with the numbers: The Department of Justice (DOJ) released its report on settlements and recoveries later than usual, with the figures not becoming public till mid-February. But while the timing was different, the content was much the same. In fiscal year 2023, DOJ recovered over $2.68 billion in settlements and judgments from civil FCA cases. That represents an increase of nearly $500 million from 2022 when the total was just over $2.2 billion.

Once again, the healthcare industry led the way among targeted industries...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, Provider, Regulations
ATA Action Raises Concerns Over DEA Telemedicine Proposed Rule
The Perfect Storm facing the Healthcare Workforce: Eight Current Issues frame the Challenge
DEA's draft special telehealth reg rule should be tossed, healthcare orgs say
Express Scripts, Caremark, Optum Rx plan to appeal effort to block FTC lawsuit
Trump administration, pharma clash: 4 notes

Share This Article